Skip to main content
  1. Market Insights
  2. Health
  3. Pharmaceuticals

Other Pharmaceuticals - Turkmenistan

Turkmenistan
  • The Other Pharmaceuticals market in Turkmenistan is expected to see a significant increase in revenue, with projections indicating that it will reach US$157.13m in 2025.
  • Furthermore, it is anticipated that the market will continue to grow at a steady pace, with an annual growth rate (CAGR 2025-2029) of 5.15%.
  • This growth trajectory is expected to result in a market volume of US$192.10m by 2029.
  • When compared globally, it is worth noting that United States is projected to generate the highest revenue in this market, with an estimated amount of US$270.12bn in 2025.
  • The Turkmenistani market for other pharmaceuticals is seeing a surge in demand due to the government's focus on improving healthcare infrastructure and increasing access to medication.

Definition:
The market Other Pharmaceuticals covers revenues for areas that are not specifically mentioned in the other markets, such as psychotropic or gastroenterology drugs and less expensive but widely used drugs, such as cold and cough remedies or analgesics.

Additional information:
Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).

In-Scope
  • Psychotropic drugs
  • Gastroenterology
  • Cold and cough remedies
  • Antibiotics
  • Women's health
  • Analgesics
Out-Of-Scope
  • Veterinary drugs
  • Medical devices
Pharmaceuticals: market data & analysis - Cover

Market Insights report

Pharmaceuticals: market data & analysis
Study Details

    Revenue

    Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.

    Most recent update:

    Source: Statista Market Insights

    Notes: The chart “Comparable Estimates” shows the forecasted development of the selected market from different sources. Please see the additional information for methodology and publication date.

    Most recent update:

    Analyst Opinion

    The Other Pharmaceuticals market in Turkmenistan has been showing signs of growth in recent years.

    Customer preferences:
    Turkmenistan has a growing population with an increasing demand for healthcare services. The government has been investing in the healthcare sector, which has resulted in an increase in demand for pharmaceuticals. Customers in Turkmenistan prefer locally produced pharmaceuticals, which are considered to be of high quality and affordable.

    Trends in the market:
    The Other Pharmaceuticals market in Turkmenistan has been growing in recent years due to the increasing demand for healthcare services. The market has been driven by the government's investment in the healthcare sector, which has resulted in an increase in demand for pharmaceuticals. The market is dominated by locally produced pharmaceuticals, which are considered to be of high quality and affordable. The market is also seeing an increase in the number of international pharmaceutical companies entering the market.

    Local special circumstances:
    Turkmenistan is a country with a centralized economy, and the government plays a significant role in the healthcare sector. The government has been investing heavily in the healthcare sector, which has resulted in an increase in demand for pharmaceuticals. The government has also been promoting the development of the pharmaceutical industry, which has resulted in the growth of the local pharmaceutical industry.

    Underlying macroeconomic factors:
    Turkmenistan's economy is heavily dependent on its natural resources, particularly natural gas. The country has been investing in diversifying its economy, and the healthcare sector has been identified as a priority area. The government has been investing heavily in the healthcare sector, which has resulted in an increase in demand for pharmaceuticals. The government's investment in the healthcare sector has also resulted in the growth of the local pharmaceutical industry. The country's strategic location between Europe and Asia also makes it an attractive market for international pharmaceutical companies.

    Global Comparison

    Most recent update:

    Source: Statista Market Insights

    Methodology

    Data coverage:

    Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

    Modeling approach / Market size:

    Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

    Forecasts:

    In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

    Additional notes:

    Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.

    Health

    Access more Market Insights on Health topics with our featured report

    Pharmaceuticals: market data & analysis - BackgroundPharmaceuticals: market data & analysis - Cover

    Key Market Indicators

    Notes: Based on data from IMF, World Bank, UN and Eurostat

    Most recent update:

    Source: Statista Market Insights

    Explore more high-quality data on related topic

    Global pharmaceutical industry - statistics & facts

    The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.
    More data on the topic

    Contact

    Get in touch with us. We are happy to help.
    Meredith Alda
    Sales Manager

    Mon - Fri, 9am - 6pm (EST)

    Lodovica Biagi
    Director of Operations

    Mon - Fri, 9:30am - 5pm (GMT)

    Ayana Mizuno
    Junior Business Development Manager

    Mon - Fri, 10:00am - 6:00pm (JST)

    Carolina Dulin
    Group Director - LATAM

    Mon - Fri, 9am - 6pm (EST)

    Yolanda Mega
    Operations Manager

    Mon - Fri, 9am - 5pm (SGT)